DL Rimm
SCY Leung
Y Bai
AL Bane
JMS Bartlett
J Bayani
MC Chang
M Dean
C Denkert
E Enwere
C Galderisi
A Gholap
JC Hugh
A Jadhav
E Kornaga
A Laurinavicius
R Levenson
J Lima
K Miller
L Pantanowitz
T Piper
J Ruan
M Srinivasan
S Virk
Y Wu
H Yang
DF Hayes
TO Nielsen
M Dowsett
Yale University School of Medicine, New Haven, CT
Juravinski Hospital and Cancer Centre, McMaster University, Hamilton, ON, CA
Breast Oncology Program, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI
Institut fur Pathologie, Charite Campus Mitte, Berlin, Germany
Biometric Research Branch, National Cancer Institute, Bethesda, MD
University of Alberta, Edmonton, AB, Canada
Biomarkers & Companion Diagnostics Group, Edinburgh Cancer Research Centre, Edinburgh, United Kingdom
Queen's University, Kingston, ON, CA
Cancer Diagnostic Quality Assurance Services CIC, Poundbury Cancer Institute, Poundbury, Dorset, United Kingdom
Transformative Pathology, Ontario Institute for Cancer Research, Toronto, Canada
MolecularMD Corp., Portland, OR.
National Center of Pathology, Vilnius University Hospital Santariskes Clinics, Vilnius, Lithuania
Institute for Cancer Research, London, United Kingdom
University of Pittsburgh, Pittsburgh, PA
University of California, Davis Medical Center, Sacramento, CA
Mount Sinai Hospital, Toronto, ON, Canada
The University of British Columbia, Vancouver, BC, Canada
Canada
Germany
United Kingdom
United States
Lithuania
Optra Technologies P
Oncology (ONC)
Breast cancer
Solid malignancies
Alpha thalassemia mental retardation X-linked protein
Proliferation marker protein Ki-67
N/A
N/A
N/A
III
N/A
N/A
Interim